Authors

  • Rahmatova M.A., Qodirov H.N.

Keywords:

yarali kolit, hayot sifati, HRQoL, IBDQ, SF-36, yallig‘lanishli ichak kasalliklari, psixologik komorbidlik.

References

1. Benchimol E.I., Bernstein C.N., Bitton A., et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases // American Journal of Gastroenterology. — 2017. — Vol. 112, № 7. — P. 1120–1134. — DOI: 10.1038/ajg.2017.97.

2. Buran T., Gultekin G., Yilmaz N., et al. Health-related quality of life and its predictors in patients with ulcerative colitis: a cross-sectional study // BMC Gastroenterology. — 2025. — Vol. 25, № 1. — Article 112.

3. Casellas F., Ginard D., Vera I., Torrejón A. Systematic review: factors affecting quality of life in adults with inflammatory bowel disease // Alimentary Pharmacology & Therapeutics. — 2014. — Vol. 40, № 11–12. — P. 1253–1264.

4. Hinnant L., Rios Villacorta N., Chen E., et al. Consensus Statement on Managing Anxiety and Depression in Individuals with Inflammatory Bowel Disease // Inflammatory Bowel Diseases. — 2025. — Vol. 31, № 5. — P. 1248–1255.

5. Kaplan G.G., Windsor J.W. The four epidemiological stages in the global evolution of inflammatory bowel disease // Nature Reviews Gastroenterology & Hepatology. — 2021. — Vol. 18, № 1. — P. 56–66. — DOI: 10.1038/s41575-020-00360-x.

6. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease // Annual Review of Immunology. — 2010. — Vol. 28. — P. 573–621. — DOI: 10.1146/annurev-immunol-030409-101225.

7. Katsoula A., Paschos P., Malandris K., et al. Systematic review and network meta-analysis: evaluating the impact of advanced therapies for moderate-to-severe ulcerative colitis on health-related quality of life // Journal of Crohn's and Colitis. — 2025. — Vol. 19, № 11. — Article jjaf210.

8. Le Berre C., Honap S., Peyrin-Biroulet L. Ulcerative colitis // The Lancet. — 2023. — №402 (10401). — P. 571–584.

9. Landeira M., Olivares D., Mañosa M., et al. Global evolution of inflammatory bowel disease incidence and prevalence: systematic review and meta-regression // Journal of Crohn's and Colitis. — 2026. — Vol. 20, № 2. — P. 198–214. — DOI: 10.1093/ ecco-jcc/jjae165.

10. Mikocka-Walus A., Knowles S.R., Keefer L., Graff L. Controversies revisited: comorbidity of depression and anxiety with IBD // Inflammatory Bowel Diseases. — 2016. — Vol. 22, № 3. — P. 752–762.

11. Ng S.C., Tang W., Ching J.Y., et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study // Gastroenterology. — 2016. — Vol. 145, № 1. — P. 158–165. — DOI: 10.1053/j.gastro.2013.04.007.

12. Ng S.C., Shi H.Y., Hamidi N., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies // The Lancet. — 2018. — Vol. 390, № 10114. — P. 2769–2778. — DOI: 10.1016/S0140-6736(17)32448-0.

13. Ng S.C., Kaplan G.G., Tang W., et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific // American Journal of Gastroenterology. — 2019. — Vol. 114, № 1. — P. 107–115. — DOI: 10.1038/s41395-018-0233-2.

14. Romberg-Camps M.J., Bol Y., Dagnelie P.C., et al. Fatigue and health-related quality of life in inflammatory bowel disease // Inflammatory Bowel Diseases. — 2010. — Vol. 16, № 12. — P. 2137–2147.

15. Rubin D.T., Ananthakrishnan A.N., Siegel C.A., et al. ACG Clinical Guideline: Ulcerative Colitis in Adults // American Journal of Gastroenterology. — 2019. — Vol. 114, № 3. — P. 384–413. — DOI: 10.14309/ajg.0000000000000152.

16. Sharara A.I., Rustom L.B., Tawil J., et al. Epidemiology of inflammatory bowel disease in developing countries: systematic review // Alimentary Pharmacology & Therapeutics. — 2024. — Vol. 59, № 5. — P. 581–601. — DOI: 10.1111/apt.17861.

17. Turner D., Ricciuto A., Lewis A. et al. STRIDE-II: an update on the Selecting Therapeutic Targets in IBD Initiative of IOIBD // Gastroenterology. — 2021. — №160(5). — P. 1570–1583.